Issue Date: September 21, 2009
Merck And Wellcome Launch Vaccine Venture
Merck & Co. and the Wellcome Trust have created a research and development joint venture focused on affordable vaccines for poor countries. The partners will invest about $130 million over the next seven years to support a staff of 60 researchers. They say the venture marks the first time a drug company and a research charity have formed such an equally funded and separate entity. It will be based in India and called MSD Wellcome Trust Hilleman Laboratories, after pioneering vaccine scientist Maurice R. Hilleman.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society